InsidersTradesSigma
Total declarations
Companies
▲ Purchases (8 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
8
Disclosed sells
1
T+90 hit rate
64%
T+90 mean return
+18.5%
Across 11 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Galindo Alejandro, Directeur Commercial. Insider active across 2 companies, notably Mannkind CORP. Cumulatively, 19 disclosures have been logged. Split: 8 buys · 1 sell. Total volume traded: €170k. Activity tracked since 18 May 2021. The latest transaction was disclosed on 28 February 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations19 total
36,900 shares@ US$2.7127.6% of flowCommon Stock,$.01 par valueSEC:0001209191-22-047428:0
5,000 shares@ US$2.934.4% of flowCommon Stock, $0.01 Par ValueSEC:0001209191-22-047423:0
1,804 shares@ US$3.171.6% of flowCommon Stock, $0.01 Par ValueSEC:0001209191-22-047421:0
4,600 shares@ US$3.85075.5% of flowCommon Stock, $0.01 Par ValueSEC:0001209191-22-047280:0
5,000 shares@ US$2.934.4% of flowCommon Stock, $0.01 Par ValueSEC:0001209191-22-043574:0
Ideal exit: 27 Apr 2023 (T+270)
4,789 shares@ US$3.190.0015% mcap8.0% of flowCommon Stock, $.01 Par ValueSEC:0001209191-22-031996:0
4,789 shares@ US$3.190.0015% mcap8.0% of flowCommon Stock, $.01 Par ValueSEC:0001209191-22-031202:0
90,000 shares0Restricted Stock UnitSEC:0001209191-22-028679:0
36,900 shares@ US$2.710.0094% mcap48.8% of flowCommon Stock,$.01 par valueSEC:0001209191-22-014102:0
Ideal exit: 25 Nov 2022 (T+270)
1,804 shares@ US$3.170.0005% mcap2.8% of flowCommon Stock, $0.01 Par ValueSEC:0001209191-22-008268:0
Ideal exit: 28 Oct 2022 (T+270)
1,804 shares@ US$3.170.0005% mcap8.0% of flowCommon Stock, $0.01 Par ValueSEC:0001209191-22-008268
Ideal exit: 28 Oct 2022 (T+270)
2,334 shares@ US$3.170.0007% mcap3.6% of flowCommon Stock, $0.01 Par ValueSEC:0001209191-22-006415:0
Ideal exit: 28 Oct 2022 (T+270)
2,334 shares@ US$3.170.0007% mcap10.3% of flowCommon Stock, $0.01 Par ValueSEC:0001209191-22-006415
Ideal exit: 28 Oct 2022 (T+270)
9,616 shares@ US$4.910.0042% mcap21.9% of flowCommon Stock, $.01 Par ValueSEC:0001209191-21-053770:0
9,616 shares@ US$4.9162.3% of flowCommon Stock, $.01 Par ValueSEC:0001209191-21-053770
5,000 shares@ US$2.990.0013% mcap6.9% of flowCommon Stock, $0.01 Par ValueSEC:0001209191-21-049137:0
Ideal exit: 26 Apr 2022 (T+270)
5,000 shares@ US$2.9919.5% of flowCommon Stock, $0.01 Par ValueSEC:0001209191-21-049137
Ideal exit: 26 Apr 2022 (T+270)
65,000 shares0Restricted Stock UnitSEC:0001209191-21-034451
65,000 shares0Restricted Stock UnitSEC:0001209191-21-034451:0
19 of 19 declarations
About Galindo Alejandro
Alejandro Galindo is the Chief Commercial Officer and EVP of the Endocrine Business Unit at MannKind Corp. In this role, he is responsible for the company's commercial strategy and operations, contributing to its development and growth. His expertise in the commercial field is essential for achieving the company's objectives.
